An update on cancer- and chemotherapy-related cognitive dysfunction: Current status

Seminars in Oncology

Volumn 38, Issue 3, 2011, Pages 431-438

  Janelsins, Michelle C ^a   Kohli, Sadhna ^b   Mohile, Supriya G ^a   Usuki, Kenneth ^a   Ahles, Tim A ^c   Morrow, Gary R ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b MAYO CLINIC   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; APOLIPOPROTEIN E; CASPASE 10; CYCLOPHOSPHAMIDE; FLUOROURACIL; INTERLEUKIN 6; INTERLEUKIN 8; METHOTREXATE; PACLITAXEL;

ANDROGEN DEPRIVATION THERAPY; BRAIN METABOLISM; BRAIN SIZE; BRAIN TUMOR; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER PATIENT; CONFERENCE PAPER; DEMENTIA; DRUG EFFECT; ELECTROENCEPHALOGRAM; EXECUTIVE FUNCTION; GENETIC VARIABILITY; HORMONAL THERAPY; HUMAN; MENOPAUSE; NEUROIMAGING; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; THROMBOCYTE ACTIVATION;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, HORMONAL; BRAIN NEOPLASMS; BREAST NEOPLASMS; COGNITION DISORDERS; FEMALE; GERIATRIC ASSESSMENT; HUMANS; MALE; NEOPLASMS; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 79956216585     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2011.03.014     Document Type: Conference Paper

References (85)

1. M. Janelsins, J.A. Roscoe, P. Jean-Pierre, and G.R. Morrow Cognitive functioning in breast cancer patients during and following chemotherapy Supplement to American Society of Clinical Oncology 47 2009 [abstract]
2. C.B. Brezden, K.A. Phillips, M. Abdolell, T. Bunston, and I.F. Tannock Cognitive function in breast cancer patients receiving adjuvant chemotherapy J Clin Oncol 18 2000 2695 2701 (Pubitemid 30463551)
3. T.A. Ahles, A.J. Saykin, and C.T. Furstenberg Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma J Clin Oncol 20 2002 485 493 (Pubitemid 34072533)
4. F.S. van Dam, S.B. Schagen, and M.J. Muller Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy J Natl Cancer Inst 90 1998 210 218 (Pubitemid 28114539)
5. J.S. Wefel, R. Lenzi, R.L. Theriault, R.N. Davis, and C.A. Meyers The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial Cancer 100 2004 2292 2299 (Pubitemid 38657875)
6. T.H. Yamada, N.L. Denburg, L.J. Beglinger, and S.K. Schultz Neuropsychological outcomes of older breast cancer survivors: cognitive features ten or more years after chemotherapy J Neuropsychiatry Clin Neurosci 22 2010 48 54
7. Cancer facts and figures 2009 American Cancer Society Atlanta, GA
8. S.B. Schagen, H.L. Hamburger, M.J. Muller, W. Boogerd, and F.S. van Dam Neurophysiological evaluation of late effects of adjuvant high-dose chemotherapy on cognitive function J Neurooncol 51 2001 159 165 (Pubitemid 32435496)
9. S. Kohli, J.J. Griggs, and J.A. Roscoe Self-reported cognitive impairments in patients with cancer J Oncol Practice 3 2007 54 59 (Pubitemid 351593688)
10. C. Quesnel, J. Savard, and H. Ivers Cognitive impairments associated with breast cancer treatments: results from a longitudinal study Breast Cancer Res Treat 116 2009 113 123
11. S.A. Reid-Arndt, A. Yee, M.C. Perry, and C. Hsieh Cognitive and psychological factors associated with early posttreatment functional outcomes in breast cancer survivors J Psychosoc Oncol 27 2009 415 434
12. M.H. Wieneke, and E.R. Dienst Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer Psychooncology 4 1995 61 66 (Pubitemid 26093776)
13. S.B. Schagen, M.J. Muller, W. Boogerd, G.J. Mellenbergh, and F.S. van Dam Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients J Natl Cancer Inst 98 2006 1742 1745 (Pubitemid 44942713)
14. A. Hurria, C. Rosen, and C. Hudis Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: a pilot prospective longitudinal study J Am Geriatr Soc 54 2006 925 931 (Pubitemid 43847029)
15. B. Collins, J. Mackenzie, A. Stewart, C. Bielajew, and S. Verma Cognitive effects of chemotherapy in post-menopausal breast cancer patients 1 year after treatment Psychooncology 18 2009 134 143
16. K. Hermelink, M. Untch, and M.P. Lux Cognitive function during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study Cancer 109 2007 1905 1913 (Pubitemid 46668557)
17. V. Jenkins, V. Shilling, and G. Deutsch A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer Br J Cancer 94 2006 828 834
18. T.A. Ahles, A.J. Saykin, and B.C. McDonald Cognitive function in breast cancer patients prior to adjuvant treatment Breast Cancer Res Treat 110 2008 143 152 (Pubitemid 351793851)
19. A. Stewart, B. Collins, J. Mackenzie, E. Tomiak, S. Verma, and C. Bielajew The cognitive effects of adjuvant chemotherapy in early stage breast cancer: a prospective study Psychooncology 17 2008 122 130 (Pubitemid 351279862)
20. L.A. Ouimet, A. Stewart, B. Collins, D. Schindler, and C. Bielajew Measuring neuropsychological change following breast cancer treatment: an analysis of statistical models J Clin Exp Neuropsychol 31 2009 73 89
21. T.A. Ahles, A.J. Saykin, and B.C. McDonald Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: impact of age and cognitive reserve J Clin Oncol 28 2010 Oct 10 4434 4440
22. C.E. Jansen, B.A. Cooper, M.J. Dodd, and C.A. Miaskowski A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients Support Care Cancer 2010 Sep 5 [Epub ahead of print]
23. J.S. Wefel, A.K. Saleeba, A.U. Buzdar, and C.A. Meyers Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer Cancer 116 2010 3348 3356
24. B.C. McDonald, S.K. Conroy, T.A. Ahles, J.D. West, and A.J. Saykin Gray matter reduction associated with systemic chemotherapy for breast cancer: a prospective MRI study Breast Cancer Res Treat 123 2010 819 828
25. S.A. Castellon, P.A. Ganz, J.E. Bower, L. Petersen, L. Abraham, and G.A. Greendale Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen J Clin Exp Neuropsychol 26 2004 955 969 (Pubitemid 39577316)
26. R.J. Ferguson, B.C. McDonald, A.J. Saykin, and T.A. Ahles Brain structure and function differences in monozygotic twins: possible effects of breast cancer chemotherapy J Clin Oncol 25 2007 3866 3870 (Pubitemid 47477262)
27. D. Galimberti, C. Fenoglio, and C. Lovati Serum MCP-1 levels are increased in mild cognitive impairment and mild Alzheimer's disease Neurobiol Aging 27 2006 1763 1768 (Pubitemid 44572579)
28. P. Bermejo, S. Martin-Aragon, and J. Benedi Differences of peripheral inflammatory markers between mild cognitive impairment and Alzheimer's disease Immunol Lett 117 2008 198 202
29. B.B. McNaull, S. Todd, B. McGuinness, and A.P. Passmore Inflammation and anti-inflammatory strategies for Alzheimer's disease - a mini-review Gerontology 56 2009 3 14
30. P.F. Smith Inflammation in Parkinson's disease: an update Curr Opin Invest Drugs 9 2008 478 484 (Pubitemid 351677901)
31. R.O. Roberts, Y.E. Geda, and D.S. Knopman Metabolic syndrome, inflammation, and nonamnestic mild cognitive impairment in older persons: a population-based study Alzheimer Dis Assoc Disord 24 2010 11 18
32. T.A. Ahles, and A.J. Saykin Candidate mechanisms for chemotherapy-induced cognitive changes Nat Rev Cancer 7 2007 192 201
33. F. Villani, A. Busia, M. Villani, C. Vismara, S. Viviani, and V. Bonfante Serum cytokine in response to chemo-radiotherapy for Hodgkin's disease Tumori 94 2008 803 808
34. L. Pusztai, T.R. Mendoza, and J.M. Reuben Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy Cytokine 25 2004 94 102 (Pubitemid 38096266)
35. P.J. Mills, S. Ancoli-Israel, and B. Parker Predictors of inflammation in response to anthracycline-based chemotherapy for breast cancer Brain Behav Immun 22 2008 98 104 (Pubitemid 350216367)
36. C.A. Meyers, M. Albitar, and E. Estey Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome Cancer 104 2005 788 793 (Pubitemid 41113679)
37. J.L. Vardy, C. Booth, and G.R. Pond Cytokine levels in patients with colorectal cancer and breast cancer and their relationship to fatigue and cognitive function J Clin Oncol 18S 2007 9070 [abstract]
38. Vardy J, Dhillon H, Xu W, et al. Cognitive function in colorectal cancer patients: interim analysis of a longitudinal prospective study [abstract]. Cognition and Cancer Meeting. March 8-9, 2010; Memorial-Sloan Kettering Cancer Center, New York, NY.
39. A.J. Fiocco, K. Lindquist, and R. Ferrell COMT genotype and cognitive function: an 8-year longitudinal study in white and black elders Neurology 74 2010 1296 1302
40. J.S. Collins, R.T. Perry, and B. Watson Association of a haplotype for tumor necrosis factor in siblings with late-onset Alzheimer disease: the NIMH Alzheimer Disease Genetics Initiative Am J Med Genet 96 2000 823 830
41. L. Bertram, M.B. McQueen, K. Mullin, D. Blacker, and R.E. Tanzi Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database Nat Genet 39 2007 17 23 (Pubitemid 46026496)
42. T.A. Ahles, A.J. Saykin, and W.W. Noll The relationship of APOE genotype to neuropsychological performance in long-term cancer survivors treated with standard dose chemotherapy Psychooncology 12 2003 612 619 (Pubitemid 37086736)
43. B.J. Small, K.S. Rawson, and E. Walsh Catechol-O-methyltransferase (COMT) genotype modulates cancer treatment-related cognitive deficits in breast cancer survivors Cancer 117 2011 1369 1376
44. K.I. Morley, and G.W. Montgomery The genetics of cognitive processes: candidate genes in humans and animals Behav Genet 31 2001 511 531 (Pubitemid 34112048)
45. T.W. McAllister, T.A. Ahles, and A.J. Saykin Cognitive effects of cytotoxic cancer chemotherapy: predisposing risk factors and potential treatments Curr Psychiatry Rep 6 2004 364 371 (Pubitemid 39591817)
46. T. Ahles, A. Saykin, and B. McDonald Genetics of cognitive decline post cancer chemotherapy [abstract] Cognition and Cancer Meeting 2010 March 8-9, 2010; Memorial-Sloan Kettering Cancer Center, New York, NY
47. G. Miller Epigenetics The seductive allure of behavioral epigenetics Science 329 2010 24 27
48. J. Pfeilschifter, R. Koditz, M. Pfohl, and H. Schatz Changes in proinflammatory cytokine activity after menopause Endocr Rev 23 2002 90 119 (Pubitemid 34185307)
49. G.A. Greendale, M.H. Huang, and R.G. Wight Effects of the menopause transition and hormone use on cognitive performance in midlife women Neurology 72 2009 1850 1857
50. K. Paraska, and C.M. Bender Cognitive dysfunction following adjuvant chemotherapy for breast cancer: two case studies Oncol Nurs Forum 30 2003 473 478
51. J.L. Palmer, T. Trotter, A.A. Joy, and L.E. Carlson Cognitive effects of tamoxifen in pre-menopausal women with breast cancer compared to healthy controls J Cancer Surviv 2 2008 275 282
52. C.M. Schilder, C. Seynaeve, and L.V. Beex Effects of tamoxifen and exemestane on cognitive functioning of postmenopausal patients with breast cancer: results from the neuropsychological side study of the tamoxifen and exemestane adjuvant multinational trial J Clin Oncol 28 2010 1294 1300
53. H. Klepin, S. Mohile, and A. Hurria Geriatric assessment in older patients with breast cancer J Natl Compr Cancer Netw 7 2009 226 236
54. S.S. Gorin, J.E. Heck, S. Albert, and D. Hershman Treatment for breast cancer in patients with Alzheimer's disease J Am Geriatr Soc 53 2005 1897 1904 (Pubitemid 41826066)
55. S.K. Gupta, and E.B. Lamont Patterns of presentation, diagnosis, and treatment in older patients with colon cancer and comorbid dementia J Am Geriatr Soc 52 2004 1681 1687 (Pubitemid 41709922)
56. J.S. Goodwin, J.M. Samet, and W.C. Hunt Determinants of survival in older cancer patients J Natl Cancer Inst 88 1996 1031 1038 (Pubitemid 26260488)
57. B.L. Plassman, K.M. Langa, and G.G. Fisher Prevalence of dementia in the United States: the aging, demographics, and memory study Neuroepidemiology 29 2007 125 132 (Pubitemid 350191430)
58. B.L. Plassman, K.M. Langa, and G.G. Fisher Prevalence of cognitive impairment without dementia in the United States Ann Intern Med 148 2008 427 434 (Pubitemid 351665442)
59. B.J. Kelley, and R.C. Petersen Alzheimer's disease and mild cognitive impairment Neurol Clin 25 2007 577 609 (Pubitemid 47058874)
60. R.C. Petersen Mild cognitive impairment as a diagnostic entity J Intern Med 256 2004 183 194 (Pubitemid 39222988)
61. M. Extermann, and M. Aapro Assessment of the older cancer patient Hematol Oncol Clin North Am 14; 2000 63 77 (Pubitemid 30078432)
62. M.B. Rodin, and S.G. Mohile A practical approach to geriatric assessment in oncology J Clin Oncol 25 2007 1936 1944 (Pubitemid 46854429)
63. A. Hurria, S. Goldfarb, and C. Rosen Effect of adjuvant breast cancer chemotherapy on cognitive function from the older patient's perspective Breast Cancer Res Treat 98 2006 343 348 (Pubitemid 44195605)
64. H. Chen, A. Cantor, and J. Meyer Can older cancer patients tolerate chemotherapy? A prospective pilot study Cancer 97 2003 1107 1114 (Pubitemid 36173165)
65. M. Extermann, J. Meyer, and M. McGinnis A comprehensive geriatric intervention detects multiple problems in older breast cancer patients Crit Rev Oncol Hematol 49 2004 69 75 (Pubitemid 38084822)
66. A. Hurria, E. Zuckerman, and K.S. Panageas A prospective, longitudinal study of the functional status and quality of life of older patients with breast cancer receiving adjuvant chemotherapy J Am Geriatr Soc 54 2006 1119 1124 (Pubitemid 43992551)
67. J.E. Heck, S.M. Albert, R. Franco, and S.S. Gorin Patterns of dementia diagnosis in Surveillance, Epidemiology, and End Results breast cancer survivors who use chemotherapy J Am Geriatr Soc 56 2008 1687 1692
68. C.J. Nelson, J.S. Lee, M.C. Gamboa, and A.J. Roth Cognitive effects of hormone therapy in men with prostate cancer: a review Cancer 113 2008 1097 1106
69. E. Salminen, R. Portin, and J. Korpela Androgen deprivation and cognition in prostate cancer Br J Cancer 89 2003 971 976 (Pubitemid 37239197)
70. H.J. Green, K.I. Pakenham, and B.C. Headley Quality of life compared during pharmacological treatments and clinical monitoring for non-localized prostate cancer: a randomized controlled trial BJU Int 93 2004 975 979 (Pubitemid 38758617)
71. S.G. Mohile, M. Lacy, and M. Rodin Cognitive effects of androgen deprivation therapy in an older cohort of men with prostate cancer Crit Rev Oncol Hematol 75 2010 152 159
72. J. Chodosh, D.B. Petitti, and M. Elliott Physician recognition of cognitive impairment: evaluating the need for improvement J Am Geriatr Soc 52 2004 1051 1059 (Pubitemid 38869062)
73. G. Blessed, B.E. Tomlinson, and M. Roth The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects Br J Psychiatry 114 1968 797 811
74. M.F. Folstein, S.E. Folstein, and P.R. McHugh "Mini-Mental State". A practical method for grading the cognitive state of patients for the clinician J Psychiatr Res 12 1975 189 198
75. S. Borson, J.M. Scanlan, P. Chen, and M. Ganguli The Mini-Cog as a screen for dementia: validation in a population-based sample J Am Geriatr Soc 51 2003 1451 1454 (Pubitemid 37259876)
76. L.M. DeAngelis, and J.B. Posner Neurologic complications of cancer side effects of chemotherapy 2009 Oxford University Press New York
77. G. Winocur, J. Vardy, M.A. Binns, L. Kerr, and I. Tannock The effects of the anti-cancer drugs, methotrexate and 5-fluorouracil, on cognitive function in mice Pharmacol Biochem Behav 85 2006 66 75 (Pubitemid 44802737)
78. G.W. Konat, M. Kraszpulski, I. James, H.T. Zhang, and J. Abraham Cognitive dysfunction induced by chronic administration of common cancer chemotherapeutics in rats Metab Brain Dis 23 2008 325 333
79. J.J. Foley, R.B. Raffa, and E.A. Walker Effects of chemotherapeutic agents 5-fluorouracil and methotrexate alone and combined in a mouse model of learning and memory Psychopharmacology (Berl) 199 2008 527 538
80. S. Mustafa, A. Walker, G. Bennett, and P.M. Wigmore 5-Fluorouracil chemotherapy affects spatial working memory and newborn neurons in the adult rat hippocampus Eur J Neurosci 28 2008 323 330
81. M.C. Janelsins, J.A. Roscoe, and M.J. Berg IGF-1 partially restores chemotherapy-induced reductions in neural cell proliferation in adult C57BL/6 mice Cancer Invest 28 2010 292 298
82. J. Dietrich, R. Han, Y. Yang, M. Mayer-Proschel, and M. Noble CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo J Biol 5 2006 22
83. R. Han, Y.M. Yang, J. Dietrich, A. Luebke, M. Mayer-Proschel, and M. Noble Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system J Biol 7 2008 12
84. J. Tangpong, M.P. Cole, and R. Sultana Adriamycin-induced, TNF-alpha-mediated central nervous system toxicity Neurobiol Dis 23 2006 127 139 (Pubitemid 44192385)
85. G. Joshi, C.D. Aluise, and M.P. Cole Alterations in brain antioxidant enzymes and redox proteomic identification of oxidized brain proteins induced by the anti-cancer drug Adriamycin: implications for oxidative stress-mediated chemobrain Neuroscience 166 2010 796 807